| abstract |
The invention relates to medicine, in particular to oncology and can be used to treat breast cancer. The essence of the invention consists in the fact that cyclophosphamide 0.6 g, adriablastin 40 mg and 5-fluorouracil 0.75 g in I and The eighth day of treatment, and from the third day, radiation therapy is performed in two fields, namely, one field includes supraclavicular, subclavian and axillary lymph nodes, and the second - directly to the mammary gland, with a dose of 3 Gy per session for each field that is performed within 10 days, with a 2-day break after the 5th se Ansa, the total dose is 30 Gy, after which surgery is performed. |